FindTrial
Sign In

hydrocortisone/placebo

OTHER2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Hormone-resistant Prostate CancerPancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaRecurrent Prostate CancerStage IV Pancreatic Cancer AJCC v6 and v7Stage IV Prostate Cancer

Phase 2

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
CompletedNCT01064622
National Cancer Institute (NCI)Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v6 and v7
Start: 2009-09-03End: 2013-01-31Updated: 2024-11-19
Saracatinib in Treating Patients With Prostate Cancer
TerminatedNCT01267266
National Cancer Institute (NCI)Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
Start: 2010-12-31End: 2013-11-30Updated: 2015-04-01

Related Papers

Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives.
2022-11-24186 citations
Molecular profiling of advanced pancreatic cancer (PC) patients from a phase I/II study using circulating tumor DNA.
Journal of Clinical Oncology2017-05-20